Dhruv Kumar

6.7k citations

190 papers · 4.4k indexed · 3 hit papers · h-index 34

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Epigenetics and DNA Methylation

Papers in ⓘ

Cancer Research 17
- Cancer, Hypoxia, and Metabolism 11
Business and International Management 2

Co-authors: Sharmila Shankar (7 shared papers)Rohit Srivastava (6 shared papers)Kavindra Kumar Kesari (18 shared papers)Janne Ruokolainen (10 shared papers)Brijesh Rathi (15 shared papers)Niraj Kumar Jha (19 shared papers)Saurabh Kumar Jha (14 shared papers)Sibi Raj (12 shared papers)
Journals: Journal of Biomolecular Structure and Dynamics (8 papers)Life Sciences (5 papers)Advances in experimental medicine and biology (4 papers)The American Journal of Surgical Pathology (4 papers)Scientific Reports (3 papers)
Partner nations: India United States Finland

In The Last Decade

Dhruv Kumar

173 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 2022 · 119 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Biology
2021 Antioxidants
2019 Seminars in Cancer Biology

Peers

Countries citing papers authored by Dhruv Kumar

Since Specialization

Citations

This map shows the geographic impact of Dhruv Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhruv Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhruv Kumar more than expected).

Fields of papers citing papers by Dhruv Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhruv Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhruv Kumar. The network helps show where Dhruv Kumar may publish in the future.

Co-authors

The 25 scholars most cited alongside Dhruv Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dhruv Kumar Line = papers co-authored together Dhruv Kumar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Oxidative Stress in Cancer Cell Metabolism Antioxidants ·Saniya Arfin, Niraj Kumar Jha, Saurabh Kumar Jha, Kavindra Kumar Kesari, Janne Ruokolainen, Shubhadeep Roychoudhury, Brijesh Rathi, Dhruv Kumar Hit paper breakdown →	2021	435
2	Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy Seminars in Cancer Biology ·Sibi Raj, Sartaj Khurana, Ramesh Choudhari, Kavindra Kumar Kesari, Mohammad Amjad Kamal, Neha Garg, Janne Ruokolainen, Bhudev C. Das, Dhruv Kumar Hit paper breakdown →	2019	324
3	Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway Cancer Letters ·Dhruv Kumar, Sharmila Shankar, Rohit Srivastava	2013	186
4	Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells Biochemical Pharmacology ·Brahma N. Singh, Dhruv Kumar, Sharmila Shankar, Rohit Srivastava	2012	180
5	Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. PubMed ·Q R Chen, Dhruv Kumar, Sanford A. Stass, A. James Mixson	1999	151
6	Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer Oncotarget ·Dhruv Kumar, Dwijendra K. Gupta, Sharmila Shankar, Rohit Srivastava	2014	137
7	Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects Biology ·Pingal Pritam, Rahul Deka, Anuradha Bhardwaj, Rashi Srivastava, Dhruv Kumar, Abhimanyu Kumar Jha, Niraj Kumar Jha, Chiara Villa, Saurabh Kumar Jha Hit paper breakdown →	2022	119
8	Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms Molecular Cancer ·Dhruv Kumar, Sharmila Shankar, Rohit Srivastava	2013	118
9	Discovery of New Hydroxyethylamine Analogs against 3CL ^pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies Journal of Chemical Information and Modeling ·Sumit Kumar, Prem P. Sharma, Uma Shankar, Dhruv Kumar, Sanjeev Kumar Joshi, Lindomar Pena, Ravi Durvasula, Amit Kumar, Prakasha Kempaiah, Poonam Poonam, Brijesh Rathi	2020	110
10	Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition Pharmacology & Therapeutics ·Sharmila Shankar, Dhruv Kumar, Rahul Srivastava	2012	108
11	Primary Low-Grade B-Cell Lymphoma of the Dura The American Journal of Surgical Pathology ·Suresh Kumar, Dhruv Kumar, Eric Kaldjian, S. C. Bauserman, Mark Raffeld, Elaine S. Jaffe	1997	106
12	Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer Molecular Cancer ·Sibi Raj, Kavindra Kumar Kesari, Arun Kumar, Brijesh Rathi, Ashok Sharma, Piyush Kumar Gupta, Saurabh Kumar Jha, Niraj Kumar Jha, Petr Sláma, Shubhadeep Roychoudhury, Dhruv Kumar	2022	105
13	Arsenic exposure in Indo Gangetic plains of Bihar causing increased cancer risk Scientific Reports ·Arun Kumar, Mohammad Ali, Ranjit Kumar, Mukesh Kumar, Prity Sagar, Ritu Pandey, Vivek Akhouri, Vikas Kumar, Gautam Anand, Pintoo Kumar Niraj, Rita Rani, Santosh Kumar, Dhruv Kumar, Akhouri Bishwapriya, Ashok Ghosh	2021	105
14	NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128 Oncogenesis ·Rajesh Nanta, Dhruv Kumar, Daniel G. Meeker, Marianna Rodova, Peter J. Van Veldhuizen, Sharmila Shankar, Rohit Srivastava	2013	91
15	Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations Journal of Molecular Neuroscience ·Niraj Kumar Jha, Shreesh Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh, Shakti D. Shukla, Dinesh Kumar Chellappan, Gaurav Gupta, Shanu Bhardwaj, Neeraj Kumar, Madhan Jeyaraman, Rashmi Jain, Sathish Muthu, Rohan Kar, Dhruv Kumar, Vineet Kumar Goswami, Janne Ruokolainen, Kavindra Kumar Kesari, Sandeep Kumar Singh, Kamal Dua	2021	85
16	Familial Tumoral Calcinosis The American Journal of Surgical Pathology ·Richard E. Slavin, Julie Wen, Dhruv Kumar, E. Burke Evans	1993	76
17	The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity Human Molecular Genetics ·Nicoletta Plotegher, Dhruv Kumar, Isabella Tessari, Marco Brucale, Francesca Munari, Laura Tosatto, Elisa Belluzzi, Elisa Greggio, Marco Bisaglia, Stefano Capaldi, Daniel Aioanei, Stefano Mammi, Hugo L. Monaco, Brunorì Samo, Luigi Bubacco	2014	57
18	In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach Vaishali Chandel, Sibi Raj, Brijesh Rathi, Dhruv Kumar	2020	55
19	Differential Diagnosis Between Monomorphic Clear Cell Adenocarcinoma of Salivary Glands and Renal (Clear) Cell Carcinoma The American Journal of Surgical Pathology ·Ricardo Bueno De Rezende, Cinthia B. Drachenberg, Dhruv Kumar, Remy H. Blanchaert, Robert A. Ord, Olga B. Ioffe, John C. Papadimitriou	1999	54
20	The Role of microRNA-21 in the Onset and Progression of Cancer Future Medicinal Chemistry ·Ashutosh Singh, Rajanish Giri, Dhruv Kumar, Rohit Sharma, Martin Vališ, Kamil Kuča, Neha Garg	2021	53

About Dhruv Kumar

Dhruv Kumar is a scholar working on Cancer Research, Business and International Management, Computational Theory and Mathematics, Reproductive Medicine and Molecular Biology, having authored 190 papers that have together received 4.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (15 papers), Cancer, Hypoxia, and Metabolism (11 papers), Potato Plant Research (9 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Heavy Metal Exposure and Toxicity (8 papers), Arsenic contamination and mitigation (7 papers), RNA modifications and cancer (6 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (577 citations), Molecular Biology (1.8k citations), Biomaterials (300 citations), Oncology (619 citations) and Pathology and Forensic Medicine (382 citations). Dhruv Kumar has collaborated with scholars based in India, United States and Finland. Frequent co-authors include Sharmila Shankar, Rohit Srivastava, Kavindra Kumar Kesari, Janne Ruokolainen, Brijesh Rathi, Niraj Kumar Jha, Saurabh Kumar Jha, Sibi Raj, Shubhadeep Roychoudhury and Saniya Arfin. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Life Sciences, Advances in experimental medicine and biology, The American Journal of Surgical Pathology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact